Mitral regurgitation is a cardiovascular condition characterized by the backward flow of blood from the left ventricle into the left atrium of the heart. This occurs when the mitral valve, responsible for regulating blood flow between these chambers, does not close properly during each heartbeat. The inefficient closure leads to a leakage of blood, causing the heart to work harder to pump a sufficient amount of blood to meet the body's needs. Mitral regurgitation can result from various causes, such as mitral valve prolapse, rheumatic heart disease, or congenital abnormalities. Common symptoms include fatigue, shortness of breath, and a distinct heart murmur. Timely diagnosis and intervention are crucial to prevent complications and manage the condition effectively, often involving medications or, in severe cases, surgical repair or replacement of the mitral valve. Management strategies aim to alleviate symptoms, improve heart function, and enhance overall quality of life for individuals affected by mitral regurgitation. Regular monitoring and collaboration with healthcare professionals are key aspects of managing this cardiovascular condition.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain